![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Novagant Corporation (PK) | USOTC:NVGT | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.0045 | 0.0045 | 0.0067 | 0.00 | 14:30:23 |
DENVER, CO--(Marketwired - April 15, 2014) - Novagant, Inc. (PINKSHEETS: NVGT) is pleased to announce the Company has relocated its main office to Denver, Colorado.
Its new office is at: Novagant Inc. 1600 Broadway Suite 1600 Denver, CO 80202 (303) 386-7342
The Company relocated its office to facility new product developments by its newly appointed Vice-President, Michael Thornton, who has extensive experience in the hemp medical industry.
About Novagant, Inc. Novagant, Inc. was incorporated in the state of Nevada on February 23, 1987 originally under the name of Kendrex Systems, Inc. The Company underwent several name changes, and ultimately on November 26, 2013 changed its name to Novagant, Inc. Please visit: www.novagant.com.
Safe Harbor:
Statements in this press release may constitute forward-looking statements and are subject to numerous risks and uncertainties, including the failure to complete successfully the development of new or enhanced products, the Company's future capital needs, the lack of market demand for any new or enhanced products the Company may develop, any actions by the Company's affiliates that may be adverse to the Company, the success of competitive products, other economic factors affecting the Company and its markets, seasonal changes, and other risks detailed from time to time in the Company's filings with the U.S. Securities and Exchange Commission. The actual results may differ materially from those contained in this press release. The Company disclaims any obligation to update any statements in this press release.
Contact: Novagant, Inc. Office@novagant.com
1 Year Novagant (PK) Chart |
1 Month Novagant (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions